Sanofi Gets CDSCO Nod for Haemophilia Drug, May Cut Bleeding Episodes
NEW DELHI: People with haemophilia A and B in India may soon have another option to prevent bleeding episodes, with the drug regulator approving Sanofi’s Qfitlia (fitusiran) for patients aged 12 years and above, including those who have developed inhibitors against conventional treatment. The Central Drugs Standard Control Organisation (CDSCO) has approved the drug for
Read the full report on Indiahealthbuddy
Story file
- Section
- Health
- Places
- Delhi
- First reported by
- Indiahealthbuddy
- Reporter
- alok uniyal
- Published
- Thursday, 22 October 2026, 6:42 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Indiahealthbuddy with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
